News from the FDA/CDC
News from the FDA/CDC
Voxelotor for sickle cell anemia now down to 4-year-olds
News from the FDA/CDC
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.
News from the FDA/CDC
FDA updates risks, cautions for clotting-bleeding disorder on Janssen COVID-19 vaccine
“The known and potential benefits of the Janssen COVID-19 vaccine outweigh its known and potential risks in individuals 18 years of age and older...
Latest News
FDA expands pembrolizumab approval for advanced melanoma
Approval was based on first interim findings from the randomized, placebo-controlled KEYNOTE-716 trial, which evaluated patients with stage IIB...
Latest News
First Omicron variant case identified in U.S.
“All close contacts have been contacted and have tested negative.”
News from the FDA/CDC
CDC: All adults should be eligible for Pfizer, Moderna boosters
More than 70 million adults are now eligible for booster shots in the United States, but only about 31 million people have received one.
News from the FDA/CDC
CDC: Thirty percent of hospital workers in U.S. still unvaccinated
Health care personnel “are not fully immune from vaccine misinformation.”
News
CDC endorses Pfizer’s COVID-19 vaccine for young kids
No cases of myocarditis were seen in the studies, but myocarditis is a very rare side effect, and the studies were too small to pick up these...
News from the FDA/CDC
COVID-19 vaccines provide 5 times the protection of natural immunity, CDC study says
“We now have additional evidence that reaffirms the importance of COVID-19 vaccines, even if you have had prior infection.”
News
FDA panel votes to approve Pfizer’s vaccine for children
If the FDA follows the recommendation, as it typically does, ...the shots could be available within days.
News from the FDA/CDC
ACIP recommends Shingrix for younger immunocompromised adults; updates pneumococcal vaccine guidance